Abstract-Proteolipids from rat cerebral cortex quenched at -196 C were extracted and fractionated at subzero temperature (-60`C). On Sephadex LH-20 column chromatography, acetylcholine and cholinergic blocking agents such as dimethyl-d tubocurarine and decamethonium were observed to bind to different fractions of pro teolipids showing that the receptor fractions for acetylcholine and that for cholinergic blockers need not be the same. The acetylcholinesterase (EC 3.1.1.7) activity was demonstrated to be absent in both types of receptor fraction. The specificities of binding by cholinergic substances to proteolipid fractions prepared at 60°C persisted at room temperature with some loss in specificity for acetylcholine. Since these speci ficities were not observed in previously reported experiments at room temperature, it appears that the structures of proteolipids extracted at the two temperatures differ. The appearance of specificities in the proteolipids prepared at low temperature suggest that their structures are in better approximation to those in vivo that presumably are highly specific. The importance of the protein moiety of proteolipids as a discriminator for the neurotransmitter is discussed.
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At the same time, the authors would like to introduce the technical details of low temperature which could be applied to studies in pharmacology.
MATERIALS AND METHODS
Preparation of protcolipids fi-oiia rat cerebral cortex at low temperature
The cerebral cortex of Sprague-Dawley rats was quenched at -196 'C in liquid nitrogen and pulverized at this temperature. The brain powder was stored at -78 °C (dry ice temper ature). The following procedures were all carried out below -60'C except column chromatography, at -60--C. Extraction of tissue to acquire a total lipid extract was done Fic,. 1. Diagram of filter for use at subzero tremperature. Container and well were precooled in dewar flask with dry ice (in methanol) to desired temperature ( 60 C). Samples were applied in the well and then filtered slowly under low vacuum. The filtrate was recovered in the container.
FIG. 2. Diagram of an apparatus for molecular distillation at subzero temperature.
Samples for molecular distillation were put in the container precooled with dry ice as in Fig. 1 . After connecting to a vacuum line which was driven by an oil pump and mercury diffusion pump, the 0-ring valve was opened slowly. The well was then filled with liquid nitrogen, thus getting a high vacuum. Using this ap paratus, 1 I of chloroform-methanol (2:1 v `v) was completely dried up in a day at 60 3C.
with chloroform-methanol (2:1 v/v, 100 ml for 100 mg of brain powder). The extraction was carried out for 20 hours with mixing. The extract was freed from residue by filtration ( Fig. 1 ). The organic solvent was completely removed under high vacuum by molecular distillation (Fig. 2) . The dried material was dissolved with chloroform-methanol (2:1 v/v) and was used as total lipid extract for chromatography and for further isolation of pro teolipids. Proteolipids were precipitated from the total lipid extract by adding twice its volume of diethyl ether (9) . The precipitate was gathered by centrifugation and the organic solvents was removed under high vacuum. The proteolipids were finally dissolved with chloroform-methanol (2:1 v/v) and allowed to react with acetylcholine and cholinergic blocking agents.
Preparation of ' Sephadex LH-20 column
Sephadex LH-20 (Pharmacia Fine Chemicals, Uppsala) previously washed at room temperature according to the instruction of the manufacture except that methanol was substituted for acetone, was rinsed in pure chloroform (500 ml for 50 g of Sephadex and allowed to stand for 5 hours at room temperature for complete swelling. It was then cooled down to -60°C with gentle stirring under low vacuum thus minimizing the dis solution of air into the liquid at this temperature. The cooled Sephadex LH-20 gel was packed into the column which was put in the refrigerator cabinet (Model ULT 657, Revco) adjusted at 60"C. To acquire the homogenous packing, the gel was first transferred to the flask attached to the top of the column and packed slowly with the aid of low vacuum.
On the top of the gel, 2 cm of ignited sea sand was put to avoid the floating of gel in pure chloroform. The column was washed with 150 ml of chloroform and allowed to stand overnight to get a constant flow rate. The column was freshly prepared for each experiment and the one used in this experiment had the dimensions, 1.8 cm x 45 cm and the gel was packed to a height of 40 cm. The outlet of the column made of glass tubing (2 mm caliber) ascended to a height 10 cm below the top of the gel. For the eluants, the fraction collector (ISCO Model 272) was also put in the refrigerator cabinet. For satisfactory running of the fraction collector, all grease at the gears was removed and a small electric heater was placed below the operating unit thermally insulated from cabinet air space.
Column chromatography at low temperature (-60°C)
Column chromatography at low temperature was used to detect the bindings of acetyl choline and cholinergic blocking agents to proteolipids preparation. Proteolipids (con taining about 5 mg of protein) dissolved in 5 ml of chloroform-methanol (2:1 v/v) were incubated with 14C-acetylcholine (5X10-8 moles), dimethyl-14C-d tubocurarine (2X10-1 moles), 14C-decamethonium (2,,< 10-8 moles) or 3H-atropine (0.5 x 10-8 moles) each of which was dissolved in 0.5 ml methanol. Incubation was carried out at -60'C for 1 hour. After incubation, the mixture was applied to the Sephadex LH-20 column and eluted with chloro form (120 ml) and chloroform-methanol (4:1 v/v, 120 ml) in succession. The eluant in 3.5 ml samples was then brought up to room temperature. Assay of the protein was done by the absorption at 280 m1'2 by a Cary 14 spectrophotometer. The total phosphorus was estimated according to the method of Martin and Doty (10), after digestion of the dried samples with perchloric acid. Radioactivity in each fraction was counted by liquid scintillation. The quenching of radioactivity by the presence of chloroform or methanol was corrected so as to obtain actual dpm. Acetylcholinesterase activity was estimated using acetylthiocholine as substrate and DNTB (Dithiobisnitrobenzoic acid) as indicator (11) .
Biphasic experiments at room temperature
Biphasic distribution experiments were also done to detect the binding of radioactive acetylcholine and cholinergic blocking agents to proteolipids from rat brain.
Proteolipid preparations which were prepared at low temperature as described above were brought up to ice temperature and dissolved in chloroform-methanol (2:1 v/v). Three milliliters of this solution containing 30 ,ug of proteolipids as protein per milliliter were placed in screw topped testing tubes which were precooled to ice temperature. To this, one milliliter each of aqueous solution of 14C-acetylcholine (2 x 10-5 M), dimethyl-14C-d tubocurarine (2 x 10-5 M) or 14C-decamethonium (2 x 10-5 M) was added and mixed vigor ously for 2 min at room temperature using a Vortex JR mixer. The tubes were then centri fuged to obtain the clear separation of two phases, upper aqueous phase (2 ml) and lower organic phase (2 ml). Some parts of each phase were transferred to scintillation vials and counted for radioactivity.
Radioactive materials were from New England Nuclear (Boston, Massachusetts): 
RESULTS
Binding of 14C-acetylcholine to total lipid extract and proteolipids isolated and incubated at -60°C When 3i-f-atropine sulfate (5 10-9 moles) was incubated and applied to Sephadex LH-20 column, this was bound to the proteolipids of both peaks of the chloroform fraction and to the peak of the chloroform-methanol fraction (Fig. 6 ). 
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Even if we reduced further the amounts of atropine sulfate to 0.5 x 10-9 moles, we got the same results. However, the binding of 14C-acetylcholine to the proteolipids of the first peak of the chloroform elution was never observed even when a higher concentration of acetylcholine was used. 14C-decamethonium gave the same results as in the case of dimethyl 14C-d-tubocurarine (Fig . 7) .
Absence of acetylcholinesterase activity in cholinergic receptor fractions
In view of repeated proposals in the past that the anionic site of acetylcholinesterase might be the acetylcholine receptor (12, 13) we examined the proteolipid preparations for the activity of this enzyme. After extraction of proteolipids from brain powder with chloro form-methanol (2:1 v/v) the residue was separated by filtration and the organic solvent in the filtrate and residue was removed at subzero temperature (-68'C).
As shown on Table 1 , the acetylcholinesterase activity was well maintained in the residue and it showed about 30% increase compared to the original brain powder. However, no enzymatic activity was observed in total lipid extract or in proteolipids precipitated by diethyl ether. Efforts were made to detect even a weak activity through sonication of these preparations or the addition of diluted aqueous methanol to bring the proteolipid solute into better contact with the substrate. No activity, however was detected.
Biphasic distribution experiments at ordinary temperature At the time of these experi ments we had no appropriate biphasic system fluid at -60°C, so we turned to a system similar to the one used by G. Weber et al, (14) , who measured by means of fluorescence in an organic-aqueous biphasic system at ordinary temperature, the increase in concentration of the cholinergic agent in the organic phase because of the presence of proteolipids in this taining the proteolipids of the first peak. In the binding experiments using Sephadex LH-20 column at -60"C, acetylcholine was exclusively bound to proteolipids of the second peak but in the biphasic analysis it was bound also to the proteolipids of the first peak although to a lesser extent (Table 2) .
Proteolipids were successively precipitated from very diluted solutions (100 /tg protein/ nil) of total lipid extract below -602C by precooled diethyl ether, two volumes of the latter to one of chloroform-methanol (Table 3) .
In biphasic experiments, the binding of 14C-acetylcholine to the proteolipids was in hibited by the presence of nonradioactive dimethyl-d-tubocurarine which was initially present in the organic phase. On the contrary, the binding of dimethy-14C-d-tubocurarine to the proteolipids was not inhibited by the presence of nonradioactive acetylcholine in the organic phase, although it showed slight inhibition at a higher concentration (Fig. 9 ). The concentration.
But at a higher concentration inhibition of 14C-acetylcholine binding was observed (Fig. 10) .
The pure phospholipids such as phosphatidyl serine and monophosphatidyl inositol showed affinity to acetylcholine as well as to cholinergic blocking agents (Fig. 11 ).
DISCUSSION
Proteolipids (1) Phospholipids were dissolved in the chloroform-methanol (2:1 vjv) and diluted to the desired concentrations. The subsequent operations were the same as given in the footnote for Fig. 8 .
The low temperature technique described in this paper, the rapid quenching of cerebral cortex at -196°C in liquid nitrogen and the following procedures carried out at or below -60°C , seem to maintain the proteolipids in better approximation to the in vivo structure, since at a lower temperature, dissociation of lipids components from proteolipids would be less probable in both energy and rate determined processes and proteins maintain their conformations.
De Robertis and his associates found that some fractions of proteolipids from the cerebral cortex did bind with cholinergic blocking agents (2, 3). Similar results were reported by them that acetylcholine bound with some of the proteolipids derived from the electric organ of electric fishes (7).
We attempted similar experiments entirely at low temperature using the proteolipids prepared from rat cerebral cortex. When 14C-acetylcholine was incubated with diluted total lipid extract and applied on the Sephadex LH-20 column, good resolution was obtained in the elution peaks of proteolipids. The radioactive acetylcholine was observed in coinci dence with the second peak eluted with pure chloroform and also in the main peak eluted with chloroform-methanol (4:1 v/v). This fact does not necessarily mean that more than two binding sites existed in the proteolipids of our preparation. The Sephadex LH-20
does not act merely as gel filtration but also as partition chromatography as instructed by Pharmacia. Some of the proteolipids together with acetylcholine were tightly bound to Sephadex LH-20 depending on the binding ability of this column and were eluted with the more polar solvent mixture of chloroform-methanol (4:1 v/v).
Levinson and Keynes claimed that the coincidences of peaks of proteolipids and choli nergic agents from Sephadex LH-20 column might be misleading, because they may be caused by solvent front effects due to the increased polarity of the elution solvent mixture (15) . The fact that we obtained the same results by the delayed application of 14C-acetyl choline and proteolipids as well as when we applied the mixture of 14C-acetylcholine and proteolipids gave a strong proof that the coincidences of peaks were not artificial. Further more, by using a column longer than the one they used, we could not detect any solvent front on monitoring the change of absorbance at 254 mp.
In the previous reports, cholinergic blocking agents were usually used to label the The receptor proteolipids for acetylcholine and acetylcholinesterase may be localized very closely in vivo on the postsynaptic membrane. After acetylcholine is bound to its receptor fraction and then displays its physiological role as neurotransmitter, the following process will be the translocation of acetylcholine to the site on acetylcholinesterase. In our experiment, the acetylcholinesterase activity in the residue was increased somewhat 30 % after removal of the proteolipids from the tissue. One possibility is that the proteoli pids may act as an intrinsic inhibitor of ace tylcholinesterase, although we did not estimate the enzyme activity of residue when it was reconstituted with proteolipids. Once acetyl choline bound with the proteolipids, their inhibitory action would be diminished causing an increase in this enzyme activity necessary for the hydrolysis of acetylcholine. The receptor proteolipid could then have a regulatory function. The importance of cholinergic receptor protein as a regulatory protein was extensively studied and discussed by Changeux et al (18) (19) (20) in Electrophorus electric organ.
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As a conclusion, the extraction and fractionation of proteolipids from rat cerebral cortex at subzero rather than ordinary temperatures yielded preparations apparently in closer correspondence to physiological states. These preparations strongly indicate that the acetylcholine receptor fraction and that for cholinergic blocking agents are sharply differentiated and acetylcholinesterase was not present in either type of receptor fractions.
The existence of the two differentiated receptor proteolipid fractions persisted in the organic solvent despite warming to ordinary temperatures (first to O 'C, and then warming to room temperature after addition of water) as demonstrated in biphasic equilibria. These specificities unobserved in previous work at ordinary temperature suggest that extraction of proteolipids at low and ordinary temperatures lead to different structures in solution.
To account for the loss in specificity of acetylcholine binding at ordinary temperature, the following mechanism is proposed. A change in the surface properties of proteolipids in the presence of water may be expected to have some resemblance to the inversion of micellar phases as discussed by Colacicco et al (21) in their study of the surface properties of the apoprotein of proteolipids. In water, the hydrophobic structures become localized as the inner phase of the micelle while the polar structures come to the surface. In the biphasic analysis, shaking the proteolipids with a mixture of chloroform-methanol and water would induce polar groups previously within the inner structure to come to the surface, remaining there because of the water in the organic phase. The polar groups may then bind acetylcholine to the proteolipid fraction that at low temperature in the absence of water had remained unbound.
Although successive precipitation of proteolipids with diethyl ether removed more than 70% of phospholipids from total lipid extract, the binding abilities of proteolipids for acetylcholine and dimethyl -d-tubocurarine were not changed. Free and loosely bound phospholipids seems to be removed by ether precipitation. Phospholipids are known to be components of the proteolipids. Actually, pure phospholipids such as phosphatidyl inositol and phosphatidyl serine showed affinity to acetylcholine and cholinergic blocking agents but with much decreased specificities. Therefore, although the tightly bound phos pholipids may act as a part of binding sites for cholinergic substances, the protein moiety of proteolipids seems to be of primary importance in determining the specificities of receptor fractions.
If we provisionally accept the receptor proteolipids as models for the physiological cholinergic receptors, because of the distinctly different specificities, we conclude that the receptor for acetylcholine and blockers need not be the same so that direct molecular com petition or displacement may not be a requirement for blocking the functional activity of nervous transmission. In this connection, the disparity observed in the reciprocal in hibitions of acetylcholine and dimethyl-d tubocurarine in their binding to proteolipids seems important. Physiologically, they would be localized very closely on the postsynaptic membrane and once the dimethyl-d-tubocurarine bind to its own receptor fraction, some conformational changes may take place leading to the inhibition of the acetylcholine receptor fraction to bind acetylcholine. The finding that the binding of acetylcholine to proteolipids, in biphasic experiments, was inhibited both by dinmethyl-d-tubocurarine and atropine shows that both nicotinic and muscarinic types of cholinergic receptor fraction were involved in our preparation. Recently, Barrantes c t al. have reported the separation of nicotinic and muscarinic hydrophobic protein from skeletal muscle and smooth intestinal muscle respec tively using Sephadex LH-20 column (22) . Both types of hydrophobic protein were re covered in the second peak eluted with pure chloroform, the similar fraction that bound acetylcholine in our experiment.
For further discrimination of the cholinergic receptor mechanism, we propose the use of labeled nicotine and muscarine in addition to acetylcholine and cholinergic blocking agents. The low temperature method described in this paper would be an aid to maintain the stereos pecificity of the binding site to these agonists and antagonists.
